User Account
Access your account to submit manuscripts, review papers, or track publication status.
Login to Portal Register AccountARGAPHARMA JOURNAL (Journal of Pharmaceutical Sciences) enforces a rigorous Double-Blind Peer Review policy to uphold scientific rigor, objectivity, and publishing quality. Under this policy, the identities of both the authors and the reviewers remain anonymous throughout the entire evaluation process.
Upon submission via OJS, the Managing Editor performs an initial check for scope compliance, formatting alignment with author guidelines, and preliminary plagiarism evaluation (Turnitin/iThenticate).
Manuscripts passing preliminary screening are assigned to at least two (2) independent peer reviewers possessing expertise closely aligned with the paper's subject matter.
Reviewers evaluate novelty, methodology, scientific soundness, data analysis, ethical compliance, and conclusions. Detailed constructive comments are provided anonymously to the editors.
Based on reviewers' reports, the Editor-in-Chief / Handling Editor makes one of the following decisions: Accept Submission, Revisions Required, Resubmit for Review, or Decline Submission.
Authors revise the manuscript addressing all reviewer suggestions within the designated timeframe, accompanying their revised draft with a point-by-point Response to Reviewers document.
Once revisions meet quality standards, an official Letter of Acceptance (LoA) is issued. The paper undergoes copyediting, typesetting/layouting, proofreading, and online publication.
| Review Stage | Expected Duration |
|---|---|
| Initial Desk Screening | 3 – 7 days |
| Peer Review Assessment | 2 – 4 weeks |
| Author Revision Period | 1 – 2 weeks (depending on revision scope) |
| Final Publishing Production | 1 – 2 weeks after final acceptance |
To ensure an effective double-blind review, authors must ensure that their submitted manuscript files contain no identifying information (such as author names, affiliations, or self-identifying citations).
Access your account to submit manuscripts, review papers, or track publication status.
Login to Portal Register Account
ARGAPHARMA JOURNAL berlisensi di bawah Creative Commons Attribution-ShareAlike 4.0 International License.